JE
Jenburkt Pharmaceuticals Limited
JENBURPH.BO · BSE
₹930.00 -1.59% (-₹15.00)
1M -3.94%
Market Cap ₹4.17B
P/E Ratio 12.70x
Div. Yield 2.19%
ROE 17.88%
Bulios Fair Price
₹796.8
14.3% downside
Current Price
₹930
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JENBURPH.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
87 /100
Cheap P/E 12.70x
P/B 2.12x
EV/EBITDA 9.18x
Growth
67 /100
Growing EPS growth 14.36%
Book val. growth 13.53%
Rev. growth 7.03%
Profitability
69 /100
Strong Gross margin 48.83%
FCF margin 0.00%
Net margin 19.46%
Quality
79 /100
Excellent ROIC 14.09%
Asset turnover 0.75x
ROE 17.88%
Debt
100 /100
Low Debt/Equity 0.01x
Net debt/EBITDA -0.07x
Current ratio 4.11x
Stability
85 /100
Stable Beta 0.36x
Profitable years 6
Rev. volatility 2.88%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JENBURPH.BO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ashish Uttam Bhuta
Employees
801
Headquarters
Mumbai